コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 zation is consistent with that of large cell immunoblastic lymphoma.
2 iferative disorders to aggressive monoclonal immunoblastic lymphomas.
3 tologic subgroup, the large-cell diffuse and immunoblastic lymphomas.
4 e lung transplant recipient who developed an immunoblastic lymphoma 4 months after lung transplantati
5 n thus be used safely to prevent EBV-related immunoblastic lymphoma after allogeneic marrow transplan
6 a distinctive morphology bridging large-cell immunoblastic lymphoma and anaplastic large-cell lymphom
7 sistent with previous findings in large cell immunoblastic lymphomas and indicates that this enzyme m
8 ansformed lymphoblastoid cell lines and AIDS immunoblastic lymphoma, and plasma cells, as defined by
9 h Working Formulation intermediate grade and immunoblastic lymphomas (exclusive of mantle cell) and s
10 mphoma and most high-grade tumors, including immunoblastic lymphomas, expressed minimal amounts of hs
11 ve prophylaxis and treatment of EBV-positive immunoblastic lymphoma in immunocompromised patients.
12 n-Barr virus (EBV) causes potentially lethal immunoblastic lymphoma in up to 25% of children receivin
13 s, showed them to be most closely related to immunoblastic lymphomas, less so to plasmacytomas of Fas
14 R1 alterations lead to a striking extranodal immunoblastic lymphoma phenotype that mimics the human d
15 lly significant class of AIDS NHL designated immunoblastic lymphoma plasmacytoid (AIDS IBLP) lacks an
16 not receive prophylaxis and developed overt immunoblastic lymphoma responded fully to T-cell infusio
18 bset of patients with intermediate-grade and immunoblastic lymphoma, the 3-year DFS was 89% (95% CI,
19 newly diagnosed patients with large-cell and immunoblastic lymphoma who participated in prospective c
20 were 42 patients with intermediate-grade or immunoblastic lymphoma who were considered to be high (6
21 c appearance of high-grade anaplastic/B-cell immunoblastic lymphomas, with loss of B-cell differentia